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PHypertrophic Cardiomyopathy
Effect of Obstruction on Longitudinal Left
Ventricular Shortening in Hypertrophic Cardiomyopathy
Ivan Barac, MD,* Shrikanth Upadya, MD,* Robert Pilchik, MD,* Glenda Winson, RN,*
Michael Passick, RDCS,* Farooq A. Chaudhry, MD,* Mark V. Sherrid, MD*
New York, New York
Objectives We investigated the cause of the midsystolic drop (MSD) in left ventricular (LV) ejection velocities that are ob-
served with hypertrophic cardiomyopathy (HCM) and severe obstruction.
Background Dynamic obstruction is an important determinant of symptoms and adverse outcome. The MSD in velocity and
flow occurs in patients with gradients 60 mm Hg. The nadir velocity in the LV occurs simultaneously with peak
gradient.
Methods We studied 36 patients with obstructive HCM and an MSD and compared them with 15 patients with HCM and
no obstruction and with 25 age-matched normal control subjects. We measured LV ejection velocity proximal
and distal to LV obstruction as well as tissue Doppler velocities and time intervals.
Results The duration of contraction of both the septum and lateral wall is shorter in obstructed patients with the MSD
than in nonobstructed HCM patients: septal contraction 203  68 ms vs. 271  41 ms (p  0.001). Parallel
reduction in the length of shortening was noted: 1.2  0.6 cm vs. 1.9  0.4 cm (p  0.001). The ejection veloc-
ity nadir follows the septal and lateral peak velocities by 100 ms and 60 ms, respectively. The velocity nadir oc-
curs as both walls rapidly decelerate to their premature termination: septal deceleration 79  35 cm/s2 vs. 48
 21 cm/s2 (p  0.001). With medical abolition of obstruction the MSD disappears and the duration and length
of contraction normalizes.
Conclusions These data indicate that the MSD is caused by premature termination of LV segmental shortening and is
a manifestation of systolic dysfunction. (J Am Coll Cardiol 2007;49:1203–11) © 2007 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.10.070d
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evidence of left ventricular (LV) systolic dysfunction in
bstructive hypertrophic cardiomyopathy (OHCM) has
een difficult to detect, even when severe outflow tract
bstruction is present. Ejection time is increased, an abnor-
ality that has been attributed to obstruction because such
rolongation occurs in valvular aortic stenosis but has not
een observed in nonobstructive hypertrophic cardiomyo-
athy (NOHCM) (1). Yet, conventional LV ejection frac-
ion (EF) often is actually increased in OHCM (2). Re-
ently a midsystolic drop (MSD) in Doppler LV ejection
elocity of 50% has been observed in patients with
radients 60 mm Hg, followed by a later second peak in
elocity (3). Volumetric ejection flow has also been shown to
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ccepted October 23, 2006.ecrease and then recover (4). The drop in Doppler velocity
as been termed the “lobster claw abnormality” because of
ts typical appearance (3). In the present study we investi-
ated the cause of the MSD by measuring longitudinal
issue Doppler imaging (TDI) velocities in HCM patients
ith severe obstruction, comparing them with nonobstruc-
ive patients and normal control subjects. We also evaluated
he effect of medical abolition of severe gradients on LV
ow velocity and tissue velocities.
ethods
atients. Hypertrophic cardiomyopathy was diagnosed
ased on the 2-dimensional echocardiographic demonstra-
ion of a hypertrophied (wall thickness 15 mm) and
ondilated LV in the absence of another cardiac or systemic
isease capable of producing the magnitude of hypertrophy
vident (5). From consecutive studies in 208 patients from
he HCM clinic, 127 patients had obstructive HCM and 47
atients had high resting LV outflow tract (LVOT) gradi-
nts 60 mm Hg due to mitral-septal apposition and an
SD on pulsed or continuous-wave Doppler echocardio-
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(3,4). We excluded 11 patients
with left bundle branch block
(LBBB), ventricular pacemaker,
prior surgical septal myectomy,
or poor quality echocardiograms
not providing all the Doppler
and TDI data required. The re-
maining 36 patients constituted
the OHCM group. We com-
pared these patients with 2 con-
trol groups. The NOHCM
group consisted of 15 patients
with NOHCM and matched
LV wall thickness score (6),
size, and EF. These patients
had no demonstrable LVOT
Doppler echocardiographic gra-
dients at rest or after provocation
with Valsalva’s maneuver. An
LVOT obstruction was defined
s a peak instantaneous gradient 30 mm Hg. The control
roup consisted of 25 age- and gender-matched normal
ubjects with no history of cardiac disease who had normal
esting echocardiograms and normal stress echocardiograms
one for evaluation of atypical symptoms. In the course of
heir clinical care 15 patients from the OHCM group were
iven oral disopyramide to assess their clinical response;
chocardiographic measurements were repeated 2.5 h later
7). Patients gave written consent to analysis of their
chocardiograms and clinical information for research pur-
oses as approved by the institutional review board of St.
uke’s-Roosevelt Hospital Center.
chocardiography. Studies were done using a commercially
vailable system (Acuson Sequoia, Mountain View, Califor-
ia), with patients resting in left lateral decubitus position, and
ll recordings were acquired in midexpiration. Maximum LV
all thickness was assessed from the 2-dimensional echocar-
iogram, as previously described, and measurements of the
nd-diastolic wall thickness of the anterior septum, posterior
eptum, anterolateral wall, and posterior wall were made (6).
eft atrial diameter and additional 2-dimensional measure-
ents of LV end-systolic and end-diastolic volumes and
VEF were made according to guidelines (8,9).
ulsed Doppler echocardiography. In OHCM patients,
he MSD was recorded in the LV ejection flow stream 2 to 2.5
m apical of the mitral valve, as previously described (3,4) (Fig.
). For all pulsed-wave (PW) and continuous-wave (CW)
oppler measurements, the results of 3 tracings were averaged.
he velocities and intervals measured are displayed in Figure 2.
ontinuous-wave Doppler. In the OHCM patients, CW
oppler was used to measure LV outflow gradient (10). From
he apical 5-chamber view the CW interrogating beam was
laced through both the LV ejection flow and the LVOT jet.
mall adjustments in beam angle allow visualization of both
Abbreviations
and Acronyms
CW  continuous wave
EF  ejection fraction
HCM  hypertrophic
cardiomyopathy
LV  left ventricle
LVOT  left ventricular
outflow tract
MSD  midsystolic drop
NOHCM  nonobstructive
hypertrophic
cardiomyopathy
OHCM  obstructive
hypertrophic
cardiomyopathy
PW  pulsed wave
TDI  tissue Doppler
imagingignals simultaneously. With medial positioning of the beam, (itral regurgitant flow was excluded. The LV MSD may be
learly visualized superimposed on the CW LVOT jet trace.
he initial upslope and terminal downslope of the LV velocity
race are completely superimposable and congruent with the
VOT traces. The 2 traces diverge in early and then midsys-
ole when LVOT traces rise and LV velocities fall (Figs. 2 and
). There were 2 reasons why CW traces of the MSD were
referred to PW traces for comparisons between OHCM and
ontrol patients. First, the use of CW traces offers the oppor-
unity for simultaneous measurement and comparison of LV
nd LVOT velocities, thus avoiding the errors introduced by
equential measurements. Second, velocity of PW traces in the
V increase as the sample volume approaches the plane of
itral-septal contact (11). Using CW velocities for compari-
ons obviates this spatial ambiguity, because CW MSD traces
re highest modal velocities before the orifice.
Graphic representation of the velocities and intervals mea-
ured are displayed in Figure 2. Both the velocities and the
ntervals obtained with CW Doppler were compared with
orresponding velocities and intervals obtained with PW
oppler.
DI. Tissue Doppler velocities were recorded from the me-
ial (septal) and lateral mitral annulus as previously reported
Figure 1 Sampling Locations of PW and CW
Doppler in the LV and LV Outflow Tract
The midsystolic drop of left ventricular (LV) ejection velocity is recorded with
pulsed-wave (PW) Doppler in the apical 5-chamber view with the sample volume
placed approximately 2.5 cm apical to the level of the tips of mitral leaflets
(X). The continuous-wave (CW) Doppler (dashed line) traverses both the LV
outflow tract and the medial LV cavity; velocities from both sites are recorded
simultaneously.12). Aliasing velocities of 15 cm/s and sweep speed of 100
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March 20, 2007:1203–11 Obstruction and Contraction in HCMm/s were used. Doppler gain was lowered until flow artifact
as eliminated. The velocities and intervals measured are
isplayed in Figure 2. For comparison of pre- and post-
isopyramide TDI velocities, measurements were also in-
exed for heart rate by dividing the measured intervals by
heir respective RR intervals (4).
tatistics. Paired and unpaired Student t tests and analysis
f variance with Bonferroni correction were used to com-
are continuous variables. Three comparisons (OHCM,
OHCM, and control) were included in each Bonferroni
djustment. Chi-square tests compared categoric variables,
nd Fisher exact tests were used when the expected fre-
uency was 5. Correlations were assessed with Pearson’s
orrelation coefficients. A p value of 0.05 was considered
tatistically significant. The SPSS 10.0 software (SPSS,
hicago, Illinois) was used for statistical analyses.
esults
emographic, clinical, and echocardiographic parameters of
atients in the 3 groups are shown on Table 1. There were
o differences in maximal LV wall thickness, LV volumes,
F, or New York Heart Association functional class be-
ween patients with OHCM and those with NOHCM.
Figure 2 Timing of the Midsystolic Drop in LV CW Velocities
Compared With Timing of ECG and LV TDI
Graphic depiction of continuous-wave (CW) Doppler of the superimposed left
ventricular (LV) outflow tract and LV midsystolic drop velocities (top), electro-
cardiogram (ECG) (middle), and tissue Doppler imaging (TDI) traces of septal
wall (bottom). PW  pulsed-wave.lso, maximal severity of mitral regurgitation among 6HCM patients was moderate, and it did not correlate with
ny of the flow or TDI parameters.
omparison of PW and CW Doppler of MSD. In the 76
atients, a total of 228 PW, 228 CW, and 304 TDI tracings
ere digitized and measured. Examples of the LV MSD
ecorded with CW and PW Doppler are shown in Figure 3.
orrelations between the parameters of LV MSD velocities
easured by pulsed and CW Doppler were excellent, as seen
n Table 2. This validates the use of LV MSD velocities
cquired by CW Doppler simultaneously with the LVOT jet
elocities for subsequent analysis of MSD flow. The timing of
he first velocity peak, V1 (at 0.2  0.04 of total cycle
uration), was simultaneous with the timing of inflection
oint, Vi (i.e., the point at which a normal convex outflow
elocity curve becomes concave and abnormal (r 0.965; p
.0001). The nadir of the MSD, Vn (at 0.32  0.04 of cycle
ength), occurred simultaneously with peak outflow velocity:
max (r  0.999; p  0.0001). With CW Doppler, LV
elocity dropped from V1 to Vn by 63% (from 2.5  0.5 m/s
o 0.9  0.3 m/s; p  0.0001). With PW Doppler, the drop
n velocity was similar (59%).
W Doppler flow and TDI results. The CW Doppler
ow and TDI results are shown in Table 3. The heart rate was
imilar in all groups. Of the flow parameters, the patients with
HCM had, as expected, higher peak flow velocities, longer
uration of ejection flow, and later peak in ejection velocity. In
he OHCM patients, there was premature termination of
hortening of both walls, resulting in decreased velocity time
ntegral (VTI). Figure 4 compares TDI tracings of patients
ith NOHCM and those with OHCM. Premature termina-
ion of contraction was seen by a decrease in the absolute
uration of contraction time (CTime) and, even more signif-
cantly, when expressed as ratio to corresponding ejection flow
uration (CTime/ETime). As a consequence, calculated septal
nd lateral wall deceleration rate (rate of drop in contraction
elocity) was significantly higher in OHCM patients than in
OHCM patients and control subjects (Table 3).
low and TDI after gradient reduction by medica-
ions. Fifteen patients with OHCM had LVOT gradient
arkedly reduced with medical treatment (Table 4). Besides
ear normalization of peak LVOT flow velocity, there was
isappearance of the MSD. Also noted were expected findings
hat accompany successful negative inotropic therapy: prolon-
ation of pre-ejection period and shortening of duration of
jection (ETime) and time to peak ejection velocity indexed to
otal ejection flow duration (TtoVmax/ETime). Tisue Doppler
maging after gradient abolition showed no changes in peak
ontraction velocities (Vs), but significant prolongation of
Time of both walls resulted in increased VTI in both septum
nd lateral walls. Figure 5 shows the post-treatment normal-
zation of the ratio of contraction time to ejection time of both
he septum and lateral wall.
In OHCM patients dyssynchronous delays are detected
n the onset, peak, and end of lateral shortening compared
ith septal shortening, as shown in Table 5. In the extreme,
OHCM patients had 60 ms delay of onset lateral
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Obstruction and Contraction in HCM March 20, 2007:1203–11hortening compared with onset septal shortening, and 6
atients had 60 ms delay in peak lateral shortening. After
harmacologic treatment, all of these delays are significantly
educed, as shown in Table 6.
Figure 3 Midsystolic Drop in LV Velocity Seen on CW and PW T
(Left) Continuous-wave (CW) Doppler through the left ventricular outflow tract (LVO
curve (arrowheads) is seen superimposed on the higher LVOT ejection flow velocit
LVOT. Long arrow points to the nadir of LV MSD flow velocity.
emographic and Baseline Echocardiographic Dataf Patients With OHCM, Patients With NOHCM, andontrol Subjects
Table 1
Demographic and Baseline Echocardiographic Data
of Patients With OHCM, Patients With NOHCM, and
Control Subjects
Variable OHCM NOHCM Control p Value
Age 61 17 48 13* 65 18 0.008
Gender (M/F) 14/22 8/7 9/16 NS
NYHA functional class
(I/II/III/IV)
2/4/22/8 5/6/4/0 25/0/0/0 0.0001
Maximal LV wall
thickness
23.5 3.1 22.6 2.3 10.4 1.3† 0.001
LVEF 0.81 0.07 0.73 0.14 0.65 0.04‡ 0.016
LVOT gradient (mm Hg) 132.3 55.3 N/A N/A N/A
Beta-blockers (%) 64 60 52 NS
Calcium-channel
blockers (%)
17 20 24 NS
NOHCM versus both; †control versus both; ‡control versus OHCM.
LV left ventricle; LVEF left ventricular ejection fraction; LVOT left ventricular outflow tract;
OHCM  nonobstructive hypertrophic cardiomyopathy; NYHA  New York Heart Association;
HCM  obstructive hypertrophic cardiomyopathy.
d
mraphic presentation. To present relationships between LV
ow, LVOT flow, and septal and lateral wall TDI more
raphically, we used pooled data from the 3 patient groups as
ell as the OHCM patients after pharmacologic gradient
bolition to construct representative flow-TDI curves. These
ow-TDI curves are presented in Figures 6 and 7. Figure 6
hows outflow and TDI velocities in normal control subjects
top) and NOHCM patients (bottom). Figure 7 shows curves
gs
bstructive hypertrophic cardiomyopathy. The midsystolic drop (MSD) flow velocity
al. (Right) Pulsed-wave (PW) Doppler recording just apical of the entrance to the
orrelation of PW Doppler andW Doppler Velocities and Time Intervals
Table 2 Correlation of PW Doppler andCW Doppler Velocities and Time Intervals
Modality Variable PW Doppler CW Doppler r p Value
Flow velocity V1 2.64 0.56 2.45 0.50 0.979 0.001
(m/s) Vn 1.07 0.37 0.91 0.33 0.948 0.001
V2 1.77 0.49 1.48 0.40 0.893 0.001
Time interval PEP 83 18 81 17 0.873 0.001
(ms) Q to V1 164 47 170 42 0.908 0.001
Q to Vn 260 60 264 65 0.944 0.001
Q to V2 355 60 351 55 0.888 0.001
ETime 324 46 323 48 0.907 0.001
W continuous-wave; ETime ejection duration; PEP pre-ejection period; PW pulsed-wave;
to V1 time to first peak; Q to V2 time to second peak; Q to Vn time to nadir of midsystolicracin
T) in o
y signrop; V1  first peak of left ventricular ejection velocity; V2  second peak; Vn  nadir of the
idsystolic drop.
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March 20, 2007:1203–11 Obstruction and Contraction in HCMrom patients with OHCM before (top) and after (bottom)
edical abolition of the gradient. In Figure 7, top, note the
imultaneous occurrence of V1 and the inflection point (Vi) on
he LVOT tracing and simultaneous occurrence of Vmax and
n. Note premature termination of both the septal and lateral
DI. Also note the delay in onset and delay in peak of
ontraction velocity of the lateral wall compared with the
eptum-systolic dyssynchrony. This delay disappears following
uccessful abolition of LVOT gradient (Fig. 7, bottom).
orrelates of the LVMSD in ejection velocity. The slope
f the MSD, the rate of drop in LV velocity from V1 to Vn,
orrelated significantly with the peak LVOT velocity (i.e., the
VOT gradient [r  0.520; p  0.002]). Duration of
ontraction of both septum and lateral wall correlated with the
iming of Vn, indexed to ejection time (r 0.556; p 0.0005;
nd r  0.537; p  0.007; for septum and lateral wall,
espectively).
orrelates of V1. The V1 correlates significantly with LVEF
r  0.495; p  0.014) and correlates negatively with LV
nd-systolic volume (r  0.422; p  0.036). When indexed
o corresponding peak LVOT velocity (V1/Vmax), the corre-
ation with LV end-systolic volume remained significant (r 
0.407; p  0.044).
iscussion
n the present study we investigated the cause of the MSD
n LV ejection velocities in patients with OHCM who have
radients 60 mm Hg. The principal findings were that in
evere obstruction, when the MSD is present, the duration
W Doppler Flow and TDI Parameters in Patients With OHCM, Pati
Table 3 CW Doppler Flow and TDI Parameters in Patients With
Modality Variable OH
CW Doppler RR (ms) 862
Vmax (m/s) 5.5
PEP (ms) 89
Q to Vmax (ms) 268
ETime (ms) 330
Q to Vmax/ETime 0.54
Septal TDI Septal Vs (cm/s) 9.5
Septal VTI (cm) 1.2
Septal PreCTime (ms) 105
Septal Q to Vs (ms) 161
Septal CTime (ms) 203
Septal CTime/ETime 0.63
Septal deceleration (cm/s2) 78
Lateral wall TDI Lateral Vs (cm/s) 11.5
Lateral VTI (cm) 1.7
Lateral PreCTime (ms) 135
Lateral Q to Vs (ms) 196
Lateral CTime (ms) 238
Lateral CTime/ETime 0.73
Lateral deceleration (cm/s2) 81
OHCM versus Control; †NOHCM versus others.
CTime  duration of contraction; PreCTime  time to onset of contraction; Q to Vmax  time to
peak flow velocity; Vs  peak systolic tissue velocity; VTI  velocity time integral of systolic tisf LV longitudinal septal and lateral wall contraction is nhortened; also, the extent (length) of longitudinal shorten-
ng is reduced, as assessed by the velocity–time integral,
ecause of the premature truncation of shortening. Specif-
cally, we found premature termination of systolic shorten-
ng in OHCM patients compared with control subjects
ithout LV hypertrophy and compared with patients with
OHCM. Moreover, after medical abolition of LV outflow
radient, duration of contraction is prolonged and normal-
zed and the MSD is no longer seen. The extent of the
remature termination of shortening is particularly apparent
hen compared with the ejection time of flow (Fig. 7, top).
he ratio CTime/ETime was only 0.63 for septum and 0.73
or lateral wall, emphasizing the premature termination of
ontraction. In contrast, this ratio was close to identity in
ormal subjects and NOHCM patients (Fig. 6).
The ejection velocity nadir follows the septal and lateral peak
elocities by 100 ms and 60 ms, respectively. The flow nadir
ccurs as both walls rapidly decelerate to their premature
ermination (Fig. 7, top). Because of these observations—
remature termination of shortening and normalization of
oth duration and extent of shortening after gradient
bolition—we suggest that premature termination of
ongitudinal shortening is the primary cause of the MSD.
We also investigated the hypothesis that dyssynchrony of
egmental contraction might contribute to the MSD. In
HCM there was an average 30-ms delay in the onset of
ateral shortening that was not seen in NOHCMpatients or in
ormal subjects. Six of these patients had delays of 60 ms or
ore. The delay in lateral shortening of the OHCM patients
With NOHCM, and Control Subjects
M, Patients With NOHCM, and Control Subjects
NOHCM Control p Value
934 191 966 172 NS
1.5 0.4 1.2 0.2 0.001
104 23 107 16 0.003
199 36 188 37 0.001
298 44 299 37 0.016
0.32 0.08 0.27 0.09 0.001
9.6 1.7 10.9 2.4 NS
1.9 0.4 2.0 0.4 0.001
108 28 104 13 NS
178 38 159 26 NS
271 41 273 40 0.001
0.91 0.14 0.91 0.12 0.001
48 21 52 15 0.001
11.1 2.1 11.3 2.1 NS
2.3 0.4† 1.8 0.4 0.003
106 26 116 21 0.037
185 59 177 38 NS
297 64† 258 35 0.002
1.0 0.23 0.87 0.14 0.001
52 24 59 22 0.001
jection velocity; Q to Vs  time to peak contraction velocity; TDI  tissue Doppler imaging; Vmax
city; other abbreviations as in Tables 1 and 2.ents
OHC
CM
176
1.1
18*
53
43
0.08
3.1
0.6
37
45
68
0.19
35
3.3
0.5
47
65
45
0.14
35ormalized after medical abolition of gradient. Though dys-
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Obstruction and Contraction in HCM March 20, 2007:1203–11ynchrony of segmental shortening may contribute to the
SD, we do not believe it is the primary sufficient cause,
ecause we have not observed the MSD in patients with
BBB alone. Rather, when it occurs, systolic dyssynchrony
ay be a contributing cause to the MSD and may also cause
iastolic dyssynchrony and diastolic dysfunction (13).
he midsystolic drop in LV ejection velocity. The mid-
ystolic drop in LV ejection velocity is a prominent Doppler
bnormality first observed on PW Doppler on the
-chamber apical view in the LV, 2 to 2.5 cm apical of the
itral valve (3,4). In the present study, a 60% decrease
ccurred from first peak, V1, to the nadir. The MSD is only
een in patients with LVOT gradient60 mm Hg (3). The
V flow is laminar during the MSD. It appears to be due to
he sudden imposition of afterload caused by mitral-septal
ontact and the sudden development of rapidly increasing
VOT gradient (3,4,11,14). It cannot be due to mitral
Figure 4 Septal TDI Tracing in Patient With Nonobstructive
HCM Compared With Severe Obstructive HCM
(Top) Tissue Doppler imaging (TDI) tracing of a nonobstructed patient. (Bot-
tom) TDI of a severely obstructed patient. Note the shortened duration of sys-
tolic septal contraction in the obstructed patient. The white arrows point to the
beginning and the end of septal contraction, excluding the isovolumetric con-
traction. HCM  hypertrophic cardiomyopathy.egurgitation, because it occurs on pulsed Doppler in the
D
TV apical of the mitral valve. Previously, and in the present
tudy, the timing of the nadir of the midsystolic drop has
orrelated temporally (at 0.32 of cycle length) exactly with
he timing of peak LVOT gradient (peak afterload, the
oment of maximum afterload mismatch) (3,4). The tim-
ng of V1 correlates with timing of mitral-septal contact
3,4). Moreover, not only Doppler velocity but also instan-
aneous descending and ascending aortic volumetric flow
ecreases in midsystole in patients with MSD (4,15,16).
his MSD is the likely cause of midsystolic closure of the
ortic valve seen on M-mode echocardiography and the
spike and dome” pulse tracing that was observed early after
he initial description of OHCM.
At 0.20 of cycle length, the beginning of abrupt deceler-
tion of flow velocity in the LV (V1) occurs simultaneously
ith the inflection point on the LVOT tracing (Vi) when
he velocity curve abruptly shifts from convex to the left to
oncave to the left (Fig. 3, left, and Fig. 7, top). At this
oment the pressure gradient itself starts to amplify ob-
truction (11), and the pressure gradient abruptly rises and
he LV MSD begins, because afterload has exceeded LV
egmental contractility.
Owing to continuity considerations, the fall in velocity in
he LV body while the velocity is rising in the LVOT jet is
nly explained if the orifice progressively narrows after
itral-septal contact (3,4,11,14). Progressive orifice nar-
owing occurs because the mitral valve is pushed farther into
he septum by the rising pressure difference across the mitral
eaflet (11). Orifice narrowing during systole explains the
oncave-to-the-left contour of the LVOT jet velocity seen
oppler Parameters Before and Afterradient Abolition With Disopyramide
Table 4 Doppler Parameters Before and AfterGradient Abolition With Disopyramide
Modality Variable Pre-Disop Post-Disop p Value
CW Doppler Vmax (m/s) 5.61 1.05 2.1 0.64 0.001
VTI (m) 1.01 0.19 0.44 0.13 0.001
PEP (ms) 91 17 120 23 0.001
T to Vmax (ms) 274 56 255 56 NS
ETime (ms) 337 51 298 24 0.01
T to Vmax/ETime 0.54 0.08 0.45 0.13 0.01
Septal TDI Septal Vs (cm/s) 9.0 2.8 8.6 2.2 NS
Septal VTI (cm) 1.14 0.58 1.59 0.53 0.01
Septal PreCTime
(ms)
109 40 117 34 NS
Septal CTime
(ms)
203 66 248 59 0.02
Septal CTime/
ETime
0.62 0.21 0.83 0.18 0.001
Lateral wall Lateral Vs (cm/s) 10.8 3.0 10.2 2.3 NS
TDI Lateral VTI (cm) 1.6 0.55 1.91 0.52 0.05
Lateral PreCTime
(ms)
132 51 115 25 NS
Lateral CTime
(ms)
239 43 280 48 0.01
Lateral CTime/
ETime
0.72 0.015 0.94 0.14 0.001isop  disopyramide; T to Vmax  time to peak LVOT flow velocity; other abbreviations as in
ables 1 to 3.
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March 20, 2007:1203–11 Obstruction and Contraction in HCMn CW Doppler. The orifice narrows because of the rise in
he pressure difference; the pressure difference rises because
f the decrease in the orifice. Obstruction begets further
bstruction (3,11,14).
Qin et al. (17) found that although peak pressure gradient
orrelated with minimum orifice area, the peak LVOT flow
ate appeared decreased by the reduction in the orifice. This
eduction in volumetric flow rate was elegantly demonstrated
y Conklin et al. (4), who found a negative correlation between
eak gradient and flow rate. Moreover, they showed a further
ecrease in flow rate at peak gradient after dobutamine
nfusion. The increased afterload is sufficient to slow but not
top LV ejection. The authors pointed out that the MSD is a
Figure 5 Increase in the Duration of Left Ventricular
Contraction After Gradient Abolition
Change in normalized duration of contraction (ratio of contraction time duration
to ejection flow duration [CT/ET]) of the septal (top) and lateral (bottom) walls
in 15 individual patients after gradient abolition with disopyramide.
Dyssynchrony: Lateral-Septal Delay in Onset of CVelocity, and End of Contraction (in ms) in PatiNOHCM Con rol Subje ts
Table 5
Dyssynchrony: Lateral-Septal Delay
Velocity, and End of Contraction (in
NOHCM, and Control Subjects
Lateral-septal delay in pre-contraction time (ms)
Lateral-septal delay in time to peak contraction (ms)
Lateral-septal delay in time to end of contraction (ms)*OHCM versus NOHCM.
Abbreviations as in Table 1.pecial case of afterload mismatch in which the LV is unable to
aintain a normal instantaneous ejection volume against
nstantaneous increase in afterload (4,18).
orrelates of the MSD. Patients with higher V1 (contrac-
ility relative to load) had higher LVEF and smaller end-
ystolic volumes. The rate of deceleration from V1 is greater
n patients with higher gradients. Patients with shorter
ontraction durations had earlier flow nadirs. The sequence
f early systolic events described here is summarized as
bstruction, premature termination of LV shortening, and
eceleration of ejection flow.
he second peak. The second increase in flow occurs with
corresponding increase in orifice area (4). The LVOT
radient begins to fall because myocardial shortening veloc-
ties are declining or have prematurely terminated (Fig. 7,
op). The second rise in flow and LV velocity occurs in
arallel with the fall in the LVOT pressure gradient. The
rifice reopens as the pressure gradient falls, just as it had
arrowed with the rise in gradient (11).
arlier data: myocardial velocities and afterload. In
OHCM, low-dose angiotensin II infusion, with a slight
ncrease in afterload, caused a decrease in both systolic TDI
elocities and ejection flow not detected in normal subjects
19). This model is different from the situation in dynamic
VOT obstruction, because the increase in afterload is not
onic throughout systole but occurs sharply after a period of
nimpeded flow in early systole and is much higher than
hat induced with angiotensin II. Pellerin et al. (20) showed
hortening of contraction time on pulsed TDI in patients
ith chronic coronary disease. We hypothesize that short-
ning of the duration of contraction may be one pattern of
mpaired contractility, either absolute or relative to afterload
action, Peak of ContractionWi h OHCM, Patients With
set of Contraction, Peak of Contraction
in Patients With OHCM, Patients With
CM NOHCM Control p Value
 87.2 0.71 38.2 16.6 42.1 0.029*
 114.8 4.4 83.6 27.3 71.9 NS
 157.9 36.7 146.8 10.2 68.3 0.001
ateral-Septal Delay in Onset of Contraction, Peakf Contraction V locity, and End of Contraction inH M P tients Before a d After Successfulradient Ab lition
Table 6
Lateral-Septal Delay in Onset of Contraction, Peak
of Contraction Velocity, and End of Contraction in
OHCM Patients Before and After Successful
Gradient Abolition
Pre-Gradient
Abolition
Post-Gradient
Abolition
p
Value
Lateral-septal delay in pre-
contraction time (ms)
51.7 86.8 3.6 42.8 0.015
Lateral-septal delay in time to
peak contraction (ms)
66.1 124.4 0.71 106.8 0.004
Lateral-septal delay in time to
end of contraction
151.2 176.0 29.6 49.8 0.032
HCM  obstructive hypertrophic cardiomyopathy.ontrents
in On
ms)
OH
47.3
54.1
113.6
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Obstruction and Contraction in HCM March 20, 2007:1203–11ismatch as in our OHCM patients. The normalization of
he duration of contraction after the obstruction is abolished
ith disopyramide supports this hypothesis. In addition, the
onstancy of Vs before and after disopyramide likely reflects
he balanced negative inotropic and afterload-reducing ef-
ects of the intervention.
tudy limitations. Although this was a retrospective study,
e consecutively included all OHCM patients who had the
SD. It is thus representative of all patients with this
bnormality of flow, which occurs in 84% of patients with
radients 60 mm Hg (3,4). Only shortening of the septal
Figure 6 Pooled CW Doppler and Tissue Doppler Data of
Controls and Patients With Nonobstructive HCM
(Top) Pooled data of normal controls. (Bottom) Pooled data from the nonob-
structive patients. The septal and lateral tissue Doppler imaging (TDI) veloci-
ties are depicted above the zero velocity line, and the continuous-wave (CW)
flow velocities are depicted below. Note that the TDI velocities and CW veloci-
ties are to different scales. HCM  hypertrophic cardiomyopathy; LVOT  left
ventricular outflow tract.nd lateral walls was examined in this study, but these pbservations sufficed to show both premature termination of
hortening and dyssynchrony that were reversed by medical
bolition of the gradient.
mplications and hypotheses. This study demonstrates for
he first time an adverse effect of obstruction on LV systolic
unction. In patients with high gradients, obstruction causes
Figure 7 Pooled CW and TDI Data in Obstructive HCM Before
and After Gradient Abolition With Disopyramide
The top graph shows the midsystolic drop of the left ventricular (LV) velocities
(dotted line), the premature termination of tissue Doppler imaging (TDI) veloci-
ties, especially relative to flow, and dyssynchrony of the septal and lateral wall
shortening. The bottom graph shows significant improvement in these abnor-
malities after gradient abolition. CW  continuous-wave; HCM  hypertrophic
cardiomyopathy; LVOT  left ventricular outflow tract; MSD  midsystolic drop.remature termination of systolic shortening, the MSD in
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March 20, 2007:1203–11 Obstruction and Contraction in HCMV ejection velocity, and decrease in instantaneous ejection
ow (4).
The present data refute doubts about the adverse effect of
he LVOT gradient on LV function (21). Rather than ending
arly (21), flow out of the LV occurs against the gradient, and
s prolonged by the gradient (1,4,15,16). The apparent paradox
f shorter contraction and prolonged flow is resolved by the
nderstanding that it is the gradient that causes both.
We offer hypotheses that these phenomena may be felt in 2
mportant domains which suggest clinical investigations. First,
ecause Conklin et al. (4) found a midsystolic fall in flow (and
urther decrease after gradient rise), these phenomena may
mpact heart failure symptoms by limiting increment in stroke
olume after exertion (22,23). Second, we found significantly
igher septal and lateral wall deceleration in MSD patients.
e hypothesize that forced sudden termination of contraction
ith each beat may cause cumulative deceleration injury to the
V myocardium (24,25). This may contribute to symptoms
nd mortality associated with severe obstruction (1,26). In
ddition, in the present study we have shown that relief of
bstruction completely prevents both the MSD in ejection
elocities and the premature termination of contraction. Re-
ersal of these adverse phenomena may contribute to the
mproved symptoms, hemodynamics, and survival that are
bserved after relief of obstruction (7,27,28).
onclusions
he MSD in ejection velocities and flow are caused by
remature termination of LV longitudinal segmental short-
ning.
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